(Q73551191)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223072%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Mechanisms of G-CSF- or GM-CSF-stimulated tumor cell killing by Fc receptor-directed bispecific antibodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223072%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

B Stockmeyer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223072%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

D Elsässer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223072%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Dechant

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223072%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R Repp

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223072%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Gramatzki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223072%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M J Glennie

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223072%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J G van de Winkel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223072%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

T Valerius

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223072%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223072%20AND%20SRC:MED&resulttype=core&format=json

Journal of Immunological Methods

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223072%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

248

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223072%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223072%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

103-111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223072%20AND%20SRC:MED&resulttype=core&format=json

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900346-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900346-X

Clinical significance of IgG Fc receptors and Fc gamma R-directed immunotherapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900346-X

The intriguing role of polymorphonuclear neutrophils in antitumor reactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900346-X

Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900346-X

Monoclonal antibody therapies-a 'constant' threat to cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900346-X

Surface phenotype and function of tonsillar germinal center and mantle zone B cell subsets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900346-X

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900346-X

Bispecific antibodies in cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900346-X

Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900346-X

Activated neutrophils as effector cells for bispecific antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900346-X

Immunotherapeutic perspective for bispecific antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900346-X

Human hemopoietic growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900346-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-1759(00)00346-X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223072%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference